CHARACTERISTICS OF BASAL CELL CARCINOMA EVALUATED WITH HIGH-FREQUENCY ULTRASOUND AND THEIR CORRELATION WITH THE DERMOSCOPIC FEATURES
Abstract
Background: Basal cell carcinoma (BCC) is the most common malignant skin tumour. High-frequency ultrasound (HFUS) enables non-invasive assessment of tumour depth and morphology, complementing clinical examination and dermoscopy.Objective: To determine the ultrasonographic characteristics of BCC and their correlation with dermoscopic features.Materials and Methods: This cohort-based cross-sectional study was conducted at the University Clinic of Dermatology in Skopje and included 61 BCC lesions evaluated by clinical examination, dermoscopy, and HFUS using an 18 MHz linear probe. Dermoscopic data were available for 53 lesions.Results: Three ultrasonographic shapes were identified: linear, oval, and irregular. Tumour depth differed significantly according to shape (p < 0.001), with linear lesions being the shallowest and irregular lesions the deepest. Greater tumour depth was associated with ill-defined margins (p = 0.020) and heterogeneous echotexture (p = 0.001). Clinical lesion size showed a very strong correlation with ultrasonographic width (rho = 0.960; p < 0.001) and a moderate correlation with tumour depth (rho = 0.449; p < 0.001). Fine, small telangiectasias (88.7%) and arborizing vessels (75.5%) were the predominant dermoscopic features. Arborizing vessels were associated with heterogeneous echotexture (p = 0.040), whereas ulceration was associated with ill-defined ultrasonographic margins (p = 0.025). Lesions with arborizing vessels had a greater median depth (2.1 vs. 1.8 mm), although the difference did not reach statistical significance (p = 0.054).Conclusion: HFUS provides additional information on BCC depth and morphology as a complementary diagnostic imaging method. Associations between specific dermoscopic and ultrasonographic features suggest that their combined use may be valuable in the preoperative assessment of BCC.
Keywords: basal cell carcinoma, high-frequency ultrasound, dermoscopy.
References
2. Morgan FC, Ruiz ES, Karia PS, Besaw RJ, Neel VA, Schmults CD. Factors predictive of recurrence, metastasis, and death from primary basal cell carcinoma 2 cm or larger in diameter. J Am Acad Dermatol. 2020;83(3):832-838.
3. Lomas A, Leonardi-Bee J, Bath-Hextall F. A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol. 2012;166:1069-1080.
4. Verkouteren JAC, Ramdas KHR, Wakkee M, Nijsten T. Epidemiology of basal cell carcinoma: scholarly review. Br J Dermatol. 2017;177(2):359-372.
5. Gangan R. Basal cell carcinoma: epidemiology. J Skin Sex Transm Dis. 2022;4:157-163.
6. Puckett Y, Steele RB. Basal cell carcinoma. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Updated 2025 Nov 7.
7. Gershon A, Gaillard F, Bell D, et al. WHO classification of skin tumours. Radiopaedia.org.
8. Tanese K. Diagnosis and management of basal cell carcinoma. Curr Treat Options Oncol. 2019;20(2):13.
9. Dourmishev LA, Rusinova D, Botev I. Clinical variants, stages, and management of basal cell carcinoma. Indian Dermatol Online J. 2013;4:12-17.
10. Noyce NC, Gulati A, Cleaver J. Mohs micrographic surgery: evaluation and treatment of nonmelanoma skin cancer.
11. Halip IA, Vata D, Statescu L, Salahoru P, Patrascu AI, Temelie Olinici D, Tarcau B, Popescu IA, Mocanu M, Constantin AM, Crisan M, Brihan I, Nicolescu AC, Gheuca-Solovastru L. Assessment of basal cell carcinoma using dermoscopy and high frequency ultrasound examination. Diagnostics (Basel). 2022;12(3):735.
12. Coppola R, Barone M, Zanframundo S, Devirgiliis V, Roberti V, Perrella E, Donati M, Palese E, Tenna S, Persichetti P, Panasiti V. Basal cell carcinoma thickness evaluated by high-frequency ultrasounds and correlation with dermoscopic features. Ital J Dermatol Venerol. 2021;156(5):610-615.
13. Lallas A, Apalla Z, Ioannides D, Argenziano G, Castagnetti F, Moscarella E, Zalaudek I. Dermoscopy in the diagnosis and management of basal cell carcinoma. Future Oncol. 2015;11(22):2975-2984.
14. Wortsman X, Vergara P, Castro A, Saavedra D, Bobadilla F, Sazunic I, Zemelman V, Wortsman J. Ultrasound as predictor of histologic subtypes linked to recurrence in basal cell carcinoma of the skin. J Eur Acad Dermatol Venereol. 2015;29(4):702-707.
15. Wang SQ, Liu J, Zhu QL, Zhao CY, Qu T, Li F, Wortsman X, Jin HZ. High-frequency ultrasound features of basal cell carcinoma and its association with histological recurrence risk. Chin Med J (Engl). 2019;132(17):2021-2026.
16. Barcaui E, Carvalho AC, Valiante PM, Barcaui CB. High-frequency ultrasound associated with dermoscopy in pre-operative evaluation of basal cell carcinoma. An Bras Dermatol. 2014;89(5):828-831.
17. Szalai K, Toth K, Harsing J, Gyongy M, Hollo P. High-frequency ultrasound assessment of basal cell carcinoma: correlations between histopathological subtype, vascularity, and age/sex distribution. Cancers (Basel). 2026;18(2):274.
18. Cives M, Mannavola F, Lospalluti L, Sergi MC, Cazzato G, Filoni E, Cavallo F, Giudice G, Stucci LS, Porta C, Tucci M. Non-melanoma skin cancers: biological and clinical features. Int J Mol Sci. 2020;21(15):5394.
19. Bobadilla F, Wortsman X, Munoz C, Segovia L, Espinoza M, Jemec GB. Pre-surgical high-resolution ultrasound of facial basal cell carcinoma: correlation with histology. Cancer Imaging. 2008;8(1):163-172.
20. Boostani M, Vera Morandini F, Wortsman X, et al. Dermoscopy-guided high-frequency ultrasound features of basal cell carcinoma subtypes compared with histopathology: a multicenter study. Sci Rep. 2026.
21. Siskou S, Pasquali P, Trakatelli M. High-frequency ultrasound of basal cell carcinomas: ultrasonographic features and histological subtypes, a retrospective study of 100 tumors. J Clin Med. 2023;12(12):3893.
22. Bozsanyi S, Boostani M, Farkas K, Hamilton-Meikle P, Varga NN, Szabo B, Vasanits F, Kuroli E, Meznerics FA, Lorincz K, Hollo P, Banvolgyi A, Wikonkál NM, Paragh G, Kiss N. Optically guided high-frequency ultrasound to differentiate high-risk basal cell carcinoma subtypes: a single-centre prospective study. J Clin Med. 2023;12(21):6910. doi:10.3390/jcm12216910.